Hyperglycemia: Clinical Trials

18 trials for Hyperglycemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 3 recruiting, 1 not yet recruiting, 1 terminated. 18 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 118Completed 13, Recruiting 3, Not yet recruiting 1, Terminated 1

Follow Hyperglycemia: new trials by email Literature Review of Hyperglycemia trials Research Report on Hyperglycemia

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of the pA1c®HI Postbiotic in Metabolic Regulation in Healthy Individuals With Hyperglycemia
Postbiotic - Hyperglycemias, Prediabetes
Early Phase 1Not yet recruitingGenbioma Aplicaciones SL1002027-01-072026-10-29
Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
Sanggua tablets, Placebo - Diabetes Mellitus, Type 2, Impaired Glucose Tolerance
Early Phase 1RecruitingTongji Hospital842025-05-152026-10-06
Time Restricted Eating in Sleep Apnea
Time restricted eating - Time Restricted Eating, Obstructive Sleep Apnea
Early Phase 1RecruitingUniversity of California, San Diego802024-01-052024-01-16
Glycemic Response of Whole Beans and Bean Products
Alpha galactosidase, Placebo - Healthy, Body Mass Index, Normal
Early Phase 1CompletedIowa State University212023-03-282024-10-08
Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips
Tetrahydrocannabivarin, Placebo - Metabolic Syndrome, Morbid Obesity
Early Phase 1CompletedMedical Life Care Planners, LLC562022-01-042022-10-10
Breaking up Sedentary Time to Improve Glucose Control in a Population at Risk for Developing Type 2 Diabetes
BREAK, ONE - Pre-diabetes
Early Phase 1RecruitingUniversity of Colorado, Denver662021-11-302025-07-29
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
REMD-477, Placebo Subcutaneous injection - Type 2 Diabetes, Glucose Tolerance Impaired
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio42021-11-102024-08-09
Brain Imaging in the Diabetes Prevention Program Outcomes Study
18F-MK-6240, 11C-PIB - Alzheimer Disease
Early Phase 1TerminatedJosé A. Luchsinger52019-10-012024-03-04
Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia
Insulin - Hyperglycemia
Early Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute92019-04-042023-01-20
Investigating the Role of the Polyol Pathway in the Central Nervous System Production of Fructose
Insulin, exercise, Dietary counseling - Hyperglycaemia (Diabetic)
Early Phase 1CompletedYale University82018-01-182024-02-05
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
Dichloroacetate, Placebo oral capsule - Hyperglycaemia (Diabetic)
Early Phase 1CompletedYale University212017-11-302021-01-22
Effect of Short Course of Glucocorticoid in Patients With Diabetes Mellitus(DM) Type 2
Prednisone - Diabetes, Hyperglycemia Steroid-induced
Early Phase 1CompletedCook County Health102016-06-032023-09-26
Effect of Acute Hyperglycemia on Renal Tissue Oxygenation
glucose 20% - Hyperglycemia, Glucose Intolerance
Early Phase 1CompletedCentre Hospitalier Universitaire Vaudois192015-06-012019-07-31
Investigation of the Glycemic Index of Ethiopian Honey
Provision of experimental honey - Hyperglycemia, Postprandial
Early Phase 1CompletedAddis Ababa University102015-06-012016-12-28
Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome
AMP-1915, Placebo - Metabolic Syndrome X
Early Phase 1CompletedShanghai University of Traditional Chinese Medicine602014-06-012016-01-07
Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
ePID closed loop system, hyaluronidase, Lispro-PH20 - Type 1 Diabetes
Early Phase 1CompletedYale University132013-09-012022-05-24
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients
Insulin protocol - Lymphoma, Diabetes Mellitus, Type 2
Early Phase 1CompletedWashington University School of Medicine152013-09-012018-05-07
The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite
Meal sequence 1-2-3, Meal sequence 1-3-2, Meal sequence 2-3-1 - Insulin Sensitivity, Glucose Intolerance
Early Phase 1CompletedUniversity of Copenhagen182012-10-012015-04-09

Narrower conditions

Glucose Intolerance (6)  ·  Diabetes Mellitus, Type 2 (4)  ·  Insulin Resistance (3)  ·  Metabolic Syndrome (3)  ·  Diabetes Mellitus (2)  ·  Hyperlipidemias (2)  ·  Alzheimer Disease (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Hypercholesterolemia (1)  ·  Intermittent Fasting (1)  ·  Lymphoma (1)  ·  Motor Activity (1)  ·  Obesity (1)  ·  Obesity, Morbid (1)

Broader conditions

Glucose Metabolism Disorders (18)  ·  Metabolic Diseases (18)  ·  Nutritional and Metabolic Diseases (18)  ·  Endocrine System Diseases (7)  ·  Hyperinsulinism (6)  ·  Diabetes Mellitus (5)  ·  Body Weight (3)  ·  Dyslipidemias (3)  ·  Insulin Resistance (3)  ·  Lipid Metabolism Disorders (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Behavior (2)  ·  Immune System Diseases (2)

Interventions

Insulin (2)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  Dichloroacetic Acid (1)  ·  Exercise (1)  ·  Hyaluronoglucosaminidase (1)  ·  Insulin Glargine (1)  ·  Insulin Lispro (1)  ·  Nutrition Assessment (1)  ·  Prednisone (1)  ·  alpha-Galactosidase (1)  ·  volagidemab (1)

Sponsors

Yale University (3)  ·  Addis Ababa University (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Cook County Health (1)  ·  Genbioma Aplicaciones SL (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Iowa State University (1)  ·  José A. Luchsinger (1)  ·  Medical Life Care Planners, LLC (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  Tongji Hospital (1)  ·  University of California, San Diego (1)  ·  University of Colorado, Denver (1)  ·  University of Copenhagen (1)

Countries

United States (11)  ·  China (1)  ·  Denmark (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Abera Belay, PhDCandidate (1)  ·  Anna Roshal, MD (1)  ·  Audrey Bergouignan, PhD (1)  ·  Eda Cengiz, MD, MHS (1)  ·  Gang Yuan, Professor (1)  ·  Garry Tobin, MD (1)  ·  Guang Ji, MD (1)  ·  Gulelat Haki, Professor (1)  ·  Janice Hwang, MD (1)  ·  Jose A. Luchsinger, MD (1)  ·  Kaleab Baye, Asst Prof. (1)  ·  Lars O Dragsted, Ph.D. (1)  ·  Michel Burnier, MD (1)  ·  Omar Mesarwi, MD (1)  ·  Raimund Herzog, MD (1)

Results publications

PMID 32369480, PMID 35247067

NIH funding

K23DK109284 (1), U01DK048404 (1)